Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
50.37 USD | -3.82% | -4.55% | +26.76% |
05-08 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
05-08 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.76% | 1.89B | |
+8.29% | 115B | |
+13.20% | 107B | |
-12.63% | 22.31B | |
-3.99% | 21.6B | |
-7.16% | 18.23B | |
-39.93% | 17.62B | |
+6.71% | 14.26B | |
+33.94% | 12.37B | |
-28.92% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics : Jefferies Adjusts Keros Therapeutics PT to $75 From $70, Maintains Buy Rating